IL143181A0 - Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system - Google Patents
Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous systemInfo
- Publication number
- IL143181A0 IL143181A0 IL14318199A IL14318199A IL143181A0 IL 143181 A0 IL143181 A0 IL 143181A0 IL 14318199 A IL14318199 A IL 14318199A IL 14318199 A IL14318199 A IL 14318199A IL 143181 A0 IL143181 A0 IL 143181A0
- Authority
- IL
- Israel
- Prior art keywords
- nervous system
- central nervous
- treating diseases
- azabicycloalkane derivatives
- substituted
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19854147A DE19854147A1 (de) | 1998-11-24 | 1998-11-24 | Verwendung von N-substituierten Azabicycloalkan-Derivaten zur Verwendung bei der Bekämpfung der Cocainsucht |
PCT/EP1999/008734 WO2000030639A1 (de) | 1998-11-24 | 1999-11-12 | Verwendung von n-substituierten azabicycloalkan-derivaten zur behandlung von erkrankungen des zentralen nervensystems |
Publications (1)
Publication Number | Publication Date |
---|---|
IL143181A0 true IL143181A0 (en) | 2002-04-21 |
Family
ID=7888824
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14318199A IL143181A0 (en) | 1998-11-24 | 1999-11-12 | Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP1133293A1 (bg) |
JP (1) | JP2002530333A (bg) |
KR (1) | KR20010080535A (bg) |
CN (1) | CN1328455A (bg) |
AR (1) | AR021502A1 (bg) |
AU (1) | AU1775300A (bg) |
BG (1) | BG105549A (bg) |
BR (1) | BR9915589A (bg) |
CA (1) | CA2352526A1 (bg) |
CZ (1) | CZ20011796A3 (bg) |
DE (1) | DE19854147A1 (bg) |
HK (1) | HK1040933A1 (bg) |
HR (1) | HRP20010472A2 (bg) |
HU (1) | HUP0104416A3 (bg) |
IL (1) | IL143181A0 (bg) |
NO (1) | NO20012538L (bg) |
PL (1) | PL348758A1 (bg) |
SK (1) | SK7112001A3 (bg) |
TR (1) | TR200101476T2 (bg) |
WO (1) | WO2000030639A1 (bg) |
ZA (1) | ZA200103976B (bg) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2589363A1 (en) | 2004-12-13 | 2006-06-22 | Eli Lilly And Company | Spiro derivatives as lipoxygenase inhibitors |
GB0812310D0 (en) | 2008-07-03 | 2008-08-13 | Syngenta Ltd | Novel herbicides |
MX2015009153A (es) * | 2013-01-15 | 2016-03-04 | Novartis Ag | Uso de agonistas del receptor nicotinico de acetilcolina alfa 7. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0348460A4 (en) * | 1987-11-12 | 1991-11-27 | American Home Products Corporation | Polycyclicamines with psychotropic activity |
DE4427648A1 (de) * | 1994-08-04 | 1996-02-08 | Basf Ag | N-Stubstituierte 3-Azabicyclo[3,2,0,]heptan-Derivate, ihre Herstellung und Verwendung |
DE4341403A1 (de) * | 1993-12-04 | 1995-06-08 | Basf Ag | N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung |
DE4427647A1 (de) * | 1994-08-04 | 1996-02-08 | Basf Ag | N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung |
-
1998
- 1998-11-24 DE DE19854147A patent/DE19854147A1/de not_active Withdrawn
-
1999
- 1999-11-12 WO PCT/EP1999/008734 patent/WO2000030639A1/de not_active Application Discontinuation
- 1999-11-12 PL PL99348758A patent/PL348758A1/xx not_active Application Discontinuation
- 1999-11-12 CZ CZ20011796A patent/CZ20011796A3/cs unknown
- 1999-11-12 AU AU17753/00A patent/AU1775300A/en not_active Abandoned
- 1999-11-12 CA CA002352526A patent/CA2352526A1/en not_active Abandoned
- 1999-11-12 SK SK711-2001A patent/SK7112001A3/sk unknown
- 1999-11-12 JP JP2000583522A patent/JP2002530333A/ja active Pending
- 1999-11-12 KR KR1020017006445A patent/KR20010080535A/ko not_active Application Discontinuation
- 1999-11-12 BR BR9915589-3A patent/BR9915589A/pt not_active IP Right Cessation
- 1999-11-12 EP EP99960974A patent/EP1133293A1/de not_active Withdrawn
- 1999-11-12 TR TR2001/01476T patent/TR200101476T2/xx unknown
- 1999-11-12 IL IL14318199A patent/IL143181A0/xx unknown
- 1999-11-12 HU HU0104416A patent/HUP0104416A3/hu unknown
- 1999-11-12 CN CN99813559A patent/CN1328455A/zh active Pending
- 1999-11-24 AR ARP990105979A patent/AR021502A1/es unknown
-
2001
- 2001-05-16 ZA ZA200103976A patent/ZA200103976B/en unknown
- 2001-05-23 NO NO20012538A patent/NO20012538L/no not_active Application Discontinuation
- 2001-05-30 BG BG105549A patent/BG105549A/bg unknown
- 2001-06-21 HR HR20010472A patent/HRP20010472A2/hr not_active Application Discontinuation
-
2002
- 2002-04-12 HK HK02102768.4A patent/HK1040933A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CZ20011796A3 (cs) | 2002-05-15 |
TR200101476T2 (tr) | 2001-10-22 |
WO2000030639A1 (de) | 2000-06-02 |
BG105549A (bg) | 2001-12-29 |
CA2352526A1 (en) | 2000-06-02 |
CN1328455A (zh) | 2001-12-26 |
HUP0104416A2 (hu) | 2002-04-29 |
HRP20010472A2 (en) | 2003-04-30 |
BR9915589A (pt) | 2001-08-07 |
HUP0104416A3 (en) | 2002-11-28 |
EP1133293A1 (de) | 2001-09-19 |
NO20012538D0 (no) | 2001-05-23 |
AU1775300A (en) | 2000-06-13 |
SK7112001A3 (en) | 2001-12-03 |
NO20012538L (no) | 2001-07-04 |
JP2002530333A (ja) | 2002-09-17 |
DE19854147A1 (de) | 2000-05-25 |
PL348758A1 (en) | 2002-06-03 |
AR021502A1 (es) | 2002-07-24 |
HK1040933A1 (zh) | 2002-06-28 |
ZA200103976B (en) | 2002-05-16 |
KR20010080535A (ko) | 2001-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2305605B (en) | Pipecolic acid derivatives for the treatment of neurological disorders | |
HUP0103856A3 (en) | Pharmaceutical composition for the treatment of acute disorders | |
IL139591A0 (en) | Combination therapy for treatment of bipolar disorders | |
IL138129A (en) | Composition for therapy of estrogen-associated disorders | |
IL155589A0 (en) | Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders | |
PL350679A1 (en) | Derivatives of 1-arenosulphonyl-2-arylpyrolydine and piperidine for treating central nervous system disorders | |
IL141263A0 (en) | Methods for treatment of neurological disorders | |
SI0908458T1 (sl) | Substituirani piridilmetilpiperazinovi in piperidinovi derivati, njihova priprava in njihova uporaba za zdravljenje motenj centralnega zivcnega sistema (cns) | |
EP1207874A4 (en) | METHOD FOR THE TREATMENT OF PROLIFERATIVE DISEASES | |
AU7788500A (en) | Use of substance p antagonists for influencing the circadian timing system | |
EE200000391A (et) | Triasiiniühendid kesknärvisüsteemihäirete raviks | |
HUP0104701A3 (en) | 3-tetrahydropyridin-4-yl indoles for treatment of psychotic disorders and medicaments containing the compounds | |
ATE256126T1 (de) | 5-heteroatom-alkyl substituierte 3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid derivate zur behandlung zentral nervöser system störungen | |
HK1038510B (zh) | 使用神經營養因子興奮劑治療眼神經變性疾病 | |
IL143181A0 (en) | Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system | |
HUP9902167A3 (en) | Use of phenylnaphthalene derivatives to make medicaments for treating diseases of the central nervous system | |
HUP0100365A3 (en) | Combination therapy for the treatment of aids | |
IL136949A0 (en) | 1,4-diazacycloheptane derivatives for the treatment of neurological disorders | |
PT1011678E (pt) | Utilização de mecamilamina para o tratamento de perturbações neuropsiquiátricas responsivas à nicotina. | |
GB0010496D0 (en) | Treatment of conditions of the central nervous system | |
GB9901808D0 (en) | Drugs for treatment of psychiatric and brain disorders | |
GB9821610D0 (en) | Treatment of neuropsychiatric disorders | |
GB9923551D0 (en) | Treatment of neuropsychiatric disorders | |
SI1133290T1 (en) | Use of inhibitors of acetylcholinesterase for the treatment of deliriums | |
UA25221A (uk) | Спосіб лікуваhhя розладів цеhтральhої hервової системи |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HP | Change in proprietorship |